Finerenone Reduces New-Onset AF in Patients With CKD and T2D
Because finerenone inhibits cardiac remodeling in preclinical models, investigators sought to examine its effect on new-onset AFF by analyzing data from the FIDELIO-DKD phase 3 trial.
Atrial Fibrillation
Kidney Impairment Influences Safety, Efficacy of Anticoagulants for AFib
Investigators found an incremental increase in risks from oral anticoagulants as kidney function decreased, highlighting the need for more research to better understand bleeding risk and net benefit of treatment in the CKD population.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...